DEDD activators, short for Death Effector Domain-containing DNA-binding protein activators, belong to a specific chemical class of compounds designed to modulate the activity of proteins containing Death Effector Domains (DEDs). DEDs are protein domains that play a crucial role in regulating programmed cell death, also known as apoptosis, and are typically found in proteins involved in apoptotic signaling pathways. These activators are of significant interest in the field of molecular biology and cellular research due to their ability to manipulate cell death processes, shedding light on fundamental cellular mechanisms.
DEDD activators act by specifically targeting and binding to proteins that contain DEDs, such as those in the caspase family, FLICE-like inhibitory proteins (FLIPs), and other apoptotic regulators. Through their interactions with DED-containing proteins, these activators can either promote or inhibit the activation of downstream apoptotic signals. This modulation of apoptotic pathways has broad implications for understanding the intricate balance between cell survival and death, as well as its relevance in various physiological and pathological contexts. Researchers employ DEDD activators as valuable tools in elucidating the roles of DED-containing proteins in cellular processes, enabling a deeper comprehension of how these molecules contribute to the regulation of apoptosis and, by extension, cellular fate decisions. By studying DEDD activators, scientists gain insights into the molecular intricacies that govern cell death, which can have implications in various fields of research, including cancer biology, immunology, and neurobiology. These compounds continue to be an essential resource in the quest to unravel the complex mechanisms that underlie programmed cell death and its physiological significance.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
Doxorubicin induces DNA damage and inhibits topoisomerase enzymes, directly triggering apoptotic pathways and indirectly engaging DEDD. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Camptothecin inhibits DNA topoisomerase I, leading to DNA damage and the direct activation of apoptotic pathways, with DEDD indirectly participating. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
Etoposide, a topoisomerase II inhibitor, directly causes DNA damage and activates apoptotic pathways, with DEDD indirectly involved. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
5-FU disrupts DNA synthesis, inducing DNA replication stress and directly contributing to apoptosis, with DEDD indirectly activated. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D intercalates with DNA, directly interfering with transcription and DNA-related processes, leading to the activation of apoptotic pathways and DEDD indirectly participating. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Tunicamycin inhibits protein N-glycosylation, leading to unfolded protein stress and the direct activation of apoptotic pathways, with DEDD indirectly involved in the stress response. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Valproic acid, an HDAC inhibitor, indirectly affects gene expression, leading to apoptosis regulation, with DEDD indirectly activated as part of the gene expression changes. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
Sorafenib impacts kinase signaling pathways involved in apoptosis, directly or indirectly increasing DEDD-mediated apoptotic responses. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol has been studied for its direct or indirect potential to activate apoptosis-related pathways, possibly increasing DEDD in these pathways. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine disrupts kinase signaling pathways, indirectly promoting apoptosis and DEDD involvement in cell death regulation. | ||||||